Financials data is unavailable for this security.
View more
Year on year Merck & Co Inc grew net income 6.64% from 17.12bn to 18.25bn despite relatively flat revenues.
| Gross margin | 78.55% |
|---|---|
| Net profit margin | 28.09% |
| Operating margin | 32.64% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2024, Merck & Co Inc increased its cash reserves by 92.76%, or 6.41bn. The company earned 21.47bn from its operations for a Cash Flow Margin of 33.46%. In addition the company used 7.73bn on investing activities and also paid 7.03bn in financing cash flows.
| Cash flow per share | 7.46 |
|---|---|
| Price/Cash flow per share | 16.19 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in USDView more
SmartText is unavailable
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 3.12% |
|---|---|
| Div growth rate (5 year) | 6.01% |
| Payout ratio (TTM) | 33.58% |
| EPS growth(5 years) | 32.57 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 8.02 |
More ▼
